glp-1 drugs adverse effects Comparison of between receptor agonists Gastrointestinal side effects of anti-obesity

Diabetes Obes Metab 2010

We'll also explore diagnostic methods and management strategies to help practitioners and patients handle these potentially dangerous complications effectively

While a 6-month follow-up period is commonly used to determine outcome of therapeutic interventions in IIH studies, we intend to further follow up the patients and also recruit new ones to obtain more long-term data

Int J Mol Sci (2020) 21(5):1746

That year one in eight people were thought to be living with obesity around the world (WHO 2024)

However, during clinical trials for diabetes, researchers noticed something remarkable: patients were losing significant amounts of weight as a side effect. This observation led Novo Nordisk to develop Wegovy, which gained FDA approval for chronic weight management in 2021